There is no single answer, because testosterone's effects run on separate clocks. A review in the European Journal of Endocrinology mapped the published time-courses and found the spread runs from days to years: insulin sensitivity can shift within days, sexual interest appears around three weeks, body composition takes twelve to sixteen weeks, and bone is still changing at three years.[1]
Most disappointment with TRT comes from measuring one clock against another.
The published timeline
Each entry below is the onset and the point of maximum effect as the review reported them.[1]
| Effect | First appears | Maximum |
|---|---|---|
| Insulin sensitivity | within days | — |
| Sexual interest / libido | 3 weeks | plateaus at 6 weeks |
| Quality of life | 3–4 weeks | later than onset |
| Lipids | 4 weeks | 6–12 months |
| Depressive mood | 3–6 weeks | 18–30 weeks |
| Inflammation markers | 3–12 weeks | — |
| Fat mass, lean mass, strength | 12–16 weeks | stabilise 6–12 months |
| Erythropoiesis (red cell production) | 3 months | 9–12 months |
| Glycemic control | 3–12 months | — |
| Erections and ejaculation | up to 6 months | — |
| Bone | 6 months | continues ≥ 3 years |
| PSA and prostate volume | marginal rise | plateaus at 12 months |
Two lines in that table do most of the work in setting expectations.
Sexual interest plateaus at six weeks. The review is direct: no further increments are expected beyond that point.[1] If libido has responded, it has largely finished responding by week six — waiting for more is waiting for something the data does not predict.
Erections are a different clock entirely. They may require up to six months, and they are not guaranteed. The TRAVERSE sexual function study, which enrolled 1,161 men with low libido, found testosterone improved sexual activity, hypogonadal symptoms and sexual desire compared with placebo — but not erectile function.[2]
What the first six weeks realistically look like
Working from the same timeline: energy, mood and libido are the earliest movers, with quality-of-life effects appearing at three to four weeks and mood becoming detectable in the same window but continuing to build for months.[1]
What is not happening yet is anything visible. Fat mass, lean mass and strength do not begin changing until twelve to sixteen weeks.[1] A man who starts treatment and checks the mirror at week four is reading an instrument that has not started moving.
The first month has its own article: your first month on TRT.
Why the trials look less dramatic than the anecdotes
Two of the effects men most expect are the two the large trials found least support for.
Cognition. The T-Trials cognitive study found testosterone treatment produced no improvement in memory or other cognitive measures in older men with low testosterone and age-associated memory impairment.[3] A subsequent systematic review and meta-analysis reached a similarly unsupportive conclusion.[4] This is covered in brain fog and low testosterone.
Mood. Real, replicated, and small. TRAVERSE's depression analysis found modest improvements in mood and energy — and no significant benefit in the men who met strict criteria for persistent depressive disorder.[5] See testosterone and depression.
Neither finding argues against treatment for men who are genuinely deficient. They argue against expecting treatment to do things it has been measured not to do.
When to conclude it isn't working
The timeline gives you the honest checkpoints.
At six weeks, libido has done most of what it will do.[1] If nothing at all has shifted in energy, mood or desire, that is worth raising — and worth confirming your levels are actually in the target range, which the guideline puts at mid-normal.[6]
At three to four months, body composition should be moving.[1] This is also when the standard monitoring panel falls due, which is the natural point for a structured review rather than a judgement call — see the 3-month panel.
Beyond a year, bone continues to change and lean mass can continue marginally.[1] Absence of dramatic change at twelve months is not evidence that nothing is happening.
Frequently asked questions
How soon will I feel different? Effects on quality of life manifest within three to four weeks, and sexual interest at about three weeks.[1] Insulin sensitivity may move within days, though that is not something you feel.
I'm eight weeks in and my libido hasn't changed. Should I wait? The review's finding is that sexual interest plateaus at six weeks with no further increments expected.[1] That makes eight weeks a reasonable point to review the protocol and confirm your levels — not a reason to quietly wait longer.
Why hasn't my body changed yet? Because it is not due to. Fat mass, lean mass and strength change at twelve to sixteen weeks and stabilise between six and twelve months.[1]
Does everyone respond on this schedule? No. The review's own conclusion notes considerable variation, related in part to the pharmacodynamics of the preparation used and to individual differences in androgen receptor genetics and steroid metabolism.[1] The timeline is a map of the published averages, not a promise.
Setting the clock correctly
The most useful thing to do before starting is to write down which effect matters most to you, and look up which clock it is on. It converts a vague sense of "is this working?" into a question with a date on it.
Keen connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, treatment is Keen Testosterone Spray Rx — a once-daily topical spray powered by Hypospray® transdermal delivery.
Related reading: your first month on TRT, starting TRT after 50, and the 12-year registry for what the longest follow-up available reports — and why its design limits what it can prove.
References
6 sources
- Saad F, Aversa A, Isidori AM, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol. 2011;165(5):675–685. doi:10.1530/EJE-11-0221 · PMID 21753068
- Pencina KM, Travison TG, Cunningham GR, et al. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024;109(2):569–580. doi:10.1210/clinem/dgad484 · PMID 37589949
- Resnick SM, Matsumoto AM, Stephens-Shields AJ, et al. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment. JAMA. 2017;317(7):717–727. doi:10.1001/jama.2016.21044 · PMID 28241356
- Buskbjerg CR, Gravholt CH, Dalby HR, et al. Testosterone Supplementation and Cognitive Functioning in Men—A Systematic Review and Meta-Analysis. J Endocr Soc. 2019;3(8):1465–1484. doi:10.1210/js.2019-00119 · PMID 31384712
- Bhasin S, Seidman S, Travison TG, et al. Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy. J Clin Endocrinol Metab. 2024;109(7):1814–1826. doi:10.1210/clinem/dgae026 · PMID 38205962
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 · PMID 29562364
Hypospray® is a registered trademark. Keen Meds Inc. utilizes the Hypospray® topical transdermal delivery platform under license.